Advertisement Pharmaceutical Business review - Page 2539 of 5284 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 3, 2026

IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib

China-based IMPACT Therapeutics and Pharmanovia have entered an exclusive licensing deal worth up to €423.5m ($488.3m), giving Pharmanovia rights to manufacture, develop, and commercialise senaparib in 66 countries.

Continue
IMPACT Therapeutics received approval in China in January 2025 for senaparib as first-line maintenance therapy in ovarian cancer. Credit: Jo Panuwat D / Shutterstock.com.
August 3, 2026

Ratio Therapeutics secures $70m Series C funding for cancer radiotherapy

Ratio Therapeutics will expand its pipeline into additional cancer targets and extend its technology to new tumour types. Credit: Gorodenkoff / Shutterstock.com.
July 31, 2026

miRecule and Rio Biofarma to develop RNA therapeutic delivery technologies

miRecule’s NAVIgGator platform will be combined with RBBL’s capabilities in peptide development and manufacturing. Credit: Gorodenkoff / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Resilience and Lilly to increase US medicines production with $750m investment
  2. Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular use
  3. Synlogic and Caldera sign merger agreement
  4. FDA grants fast track designation for HAYA Therapeutics’ HTX-001
  5. Eisai and CORE Biomedicine agree on global licence for oncology pipeline

PRESS RELEASES

Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography